Research Article

Total and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic Patients

Table 1

Basic metabolic and clinical characteristics of subjects.

CharacteristicsHealthyDM
FemalesMalesFemalesMales
Mean ± SD (median)Mean ± SD (median)Mean ± SD (median)Mean ± SD (median)

143126164118
Age (years) 56.8 ± 10.255.8 ± 11.462.1 ± 9.263.9 ± 8.7
BMI (kg/m²)25.3 ± 1.4 (25.5)26.7 ± 3.5 (25.7)32.03 ± 5.9 (30.83)31.84 ± 5.2 (30.77)
Waist (cm)78.5 ± 10.1 (79)85.5 ± 12.0 (83)112.5 ± 7.7 (105)113.0 ± 11.8 (111)
BP systolic (mmHg)122.53 ± 11.25 (120)128.51 ± 13.79 (130)142.17 ± 19.19 (140.5)149.31 ± 17.07 (148)
BP diastolic (mmHg)77.76 ± 8.90 (80)79.1 ± 9.12 (80)83.85 ± 11.40 (85)85.92 ± 10.17 (86)
Total cholesterol (mmol/L)4.97 ± 0.80 (4.95)5.01 ± 1.05 (4.93)5.14 ± 1.08 (5.08)5.34 ± 1.02 (4.64)
Triglycerides (mmol/L)1.3 ± 0.84 (1.08)1.57 ± 1.04 (1.35)1.98 ± 0.87 (1.81)2.24 ± 1.21 (1.8)
HDL cholesterol (mmol/L)1.71 ± 0.43 (1.69)1.33 ± 0.33 (1.29)1.32 ± 0.32 (1.27)1.18 ± 0.31 (1.15)
LDL cholesterol (mmol/L)2.68 ± 0.72 (2.62)2.98 ± 0.83 (2.92)3.17 ± 0.932 (3.16)3.0 ± 0.799 (2.92)
Glucose (mmol/L)5.16 ± 0.90 (4.9)5.4 ± 1.52 (5.1)8.39 ± 1.86 (8.22)8.43 ± 1.76 (8.4)
Insulin (mIU/L) 10.64 ± 9.08 (7.5)11.87 ± 12.73 (8.25)13.97 ± 9.40 (10.7)14.88 ± 10.62 (11.8)
ApoA-1 (g/L)1.78 ± 0.31 (1.75)1.6 ± 0.24 (1.48)1.55 ± 0.25 (1.54)1.45 ± 0.23 (1.42)
ApoB (g/L)0.86 ± 0.20 (0.84)0.96 ± 0.25 (0.94)0.96 ± 0.23 (0.94)0.92 ± 0.23 (0.9)
Total adiponectin (mg/L)10.34 ± 4.59 (7.25)8.04 ± 5.104 (6.68)5.32 ± 1.47 (5.1)5.12 ± 1.72 (4.87)
HMW adiponectin (mg/L)4.71 ± 2.64 (4)4.46 ± 2.83 (3.8)2.92 ± 0.91 (2.9)3.03 ± 1.109 (2.8)
HMW/total adiponectin ratio0.45 ± 0.09 (0.56)0.55 ± 0.06 (0.55)0.54 ± 0.07 (0.57)0.59 ± 0.07 (0.59)
HOMA IR2.54 ± 2.50 (1.58)3.0 ± 3.72 (1.99)5.28 ± 3.90 (3.97)5.65 ± 4.69 (4.25)

SD: standard deviation; M: male; F: female; BP: blood pressure; homeostasis model assessment.
HOMA IR = fasting insulin (IU/mL) × fasting glucose (mmol/L)/22.5.